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Background:  We investigated the relationships of adiponectin/leptin (A/L) ratio with cardiovascular risk factors, insulin resis-
tance index, and metabolic syndrome (MS) in apparently healthy Korean male adults. 
Methods:  Sixty-eight male subjects were enrolled among the participants of an annual health check-up program (mean age, 55.1 
years). Percent body fat (%) was measured using a bioelectric impedance analyzer. Serum leptin level was measured via radioim-
munoassay, and adiponectin level was measured using an enzyme-linked immunosorbent assay. Homeostasis model assessment 
(HOMA)-insulin resistance (IR) index was calculated, and the presence of metabolic syndrome was assessed. 
Results:  Adiponectin, leptin, and A/L ratio showed significant correlations with percent body fat, lipid profile, and HOMA-IR. 
Mean leptin and HOMA-IR levels were significantly higher, while A/L ratio was significantly lower in subjects with MS. With in-
creasing number of MS components, the mean values of leptin and HOMA-IR increased and the A/L ratio decreased. In multi-
ple regression analysis, HOMA-IR was significantly correlated with triglyceride, fasting glucose, and A/L ratio, while A/L ratio 
was significantly correlated with body mass index and HOMA-IR. HOMA-IR and A/L ratio were significant predictors for each 
other after adjustment for other factors. 
Conclusion:  A/L ratio correlated well with lipid profile, HOMA-IR, and the presence and number of MS components in Korean 
male subjects. 
Keywords:  Adiponectin/leptin ratio; Insulin resistance; Metabolic syndrome
Corresponding author:  Eun Jung Rhee
Division of Endocrinology and Metabolism, Department of Internal 
Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of 
Medicine, 108 Pyeong-dong, Jongno-gu, Seoul 110-746, Korea
E-mail: hongsiri@hanmail.net
Received: Mar. 23, 2010; Accepted: Jun. 8, 2010
INTRODUCTION
Many studies have been performed about the two adipocyto-
kines, leptin and adiponectin, among various adipocyte-derived 
cytokines thought to be involved in the regulation of metabolic 
homeostasis [1-3]. Plasma adiponectin concentration has been 
reported to decrease as the body mass index (BMI) increases 
and to correlate negatively with insulin resistance [4,5]. Leptin, 
identified from the genetic animal model of obesity, ob/ob 
mouse, shows positive correlations with adiposity and insulin 
resistance, and leptin has been suggested as a sensitive chemi-
cal marker for the diagnosis of obesity and obesity-related dis-
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ease [6,7]. A recent study showed a negative correlation of se-
rum adiponectin level and a positive correlation of serum leptin 
level with visceral fat area in Korean adults, and these correla-
tions were more significant compared with those of BMI [8]. 
More recently, the evaluation of the leptin:adiponectin ratio 
has been suggested as a useful parameter for assessing insulin 
resistance in patients with and without diabetes [9-12]. Inoue 
et al. [9,10] reported that the adiponectin/leptin (A/L) ratio 
was more effective as a parameter of insulin resistance than 
was adiponectin or leptin alone and was a more sensitive and 
reliable marker of insulin resistance than was homeostasis mod-
el assessment (HOMA)-insulin resistance (IR) in subjects with-
out hyperglycemia, as well as in type 2 diabetes patients. Recently 
published studies support the previous results on the associa-
tion of A/L ratio with insulin resistance [11,12]. Furthermore, 
recent work by Norata et al. [13] reported that leptin:adiponectin 
ratio is a powerful independent predictor of intima-media thick-
ness and other cardiometabolic parameters in healthy males. 
  Metabolic syndrome (MS) is a cluster of risk factors for ath-
erosclerotic cardiovascular disease caused by abdominal obe-
sity, such as hyperglycemia, hypertension, dyslipidemia, and 
insulin resistance [14,15]. Several studies have reported the as-
sociation of adipokines, especially A/L ratio, with the presence 
of metabolic syndrome in Chinese and Korean individuals, and 
they all support the significant role of A/L ratio in the predic-
tion of insulin resistance in subjects with or without metabolic 
syndrome and diabetes [16,17].
  In this study, we investigated the relationships of A/L ratio 
with cardiovascular risk factors, HOMA-IR, and the presence 
of metabolic syndrome in apparently healthy Korean male adults. 
We also analyzed whether A/L ratio would have a more pre-
dictable role in the assessment of insulin resistance than did 
HOMA-IR.
 
METHODS
Subjects and measurements
Sixty-eight males were enrolled among the participants in the 
annual health check-up program in MizMedi Hospital, Seoul, 
Korea from January to December 2002. Among the total 561 
male participants during the period, those with diabetes melli-
tus, hyperthyroidism, pituitary disease, hypogonadism, chronic 
liver disease, or chronic renal disease were excluded. The study 
protocol conformed to the ethical guidelines of the 1975 Dec-
laration of Helsinki, as reflected in a priori approval by the in-
stitution’s human research committee. 
  Height, weight, waist circumference, and systolic and dia-
stolic blood pressures were measured in duplicate, and the re-
sults were averaged. Weight and height were measured in kg 
and cm, respectively, down to two decimal points. The BMI 
was calculated by dividing the weight (kg) with the square of 
the height (m
2). Percent body fat (PBF, %) was measured using 
a bioelectric impedance analyzer (InBody 3.0; Biospace Co. 
Ltd., Seoul, Korea). 
  Blood samples were taken after overnight fasting; serum was 
separated, stored at -80°C, and were analyzed at a later time. 
Fasting blood glucose (FBG), total cholesterol (TC), triglycer-
ide (TG), high density lipoprotein cholesterol (HDL-C), and 
low density lipoprotein cholesterol (LDL-C) were measured. 
The hexokinase method was used to measure blood glucose lev-
els, and an enzymatic colorimetric test was used to measure the 
TC and TG levels. The selective inhibition method was used to 
measure the level of HDL-C, and the homogeneous enzymatic 
colorimetric test was used to measure the level of LDL-C (AD-
VIA 1650; Bayer Health Care, Tarrytown, NY, USA). Serum 
leptin level was measured using radioimmunoassay (LINCO 
Research, St Charles, MO, USA), and adiponectin level was mea-
sured using an enzyme-linked immunosorbent assay (B-Bridge 
International, Tokyo, Japan). The intra-assay coefficient of varia-
tion (CV) of leptin was 3.4 to 8.3%, and the inter-assay CV was 
3.0 to 6.2%. The intra-assay CV of was 4.6 to 5.8%, and the in-
ter-assay CV was 3.2 to 7.3%. 
  The presence of metabolic syndrome was defined according 
to the American Heart Association/National Heart, Lung, and 
Blood Institute (AHA/NHLBI) diagnostic criteria [18], and 
HOMA-IR was calculated using the following formula: [fasting 
insulin (mIU/mL) × fasting blood glucose (mmol/L)]/22.5 [19].
Statistical analysis
Statistical analysis was performed using SPSS for Windows 
version 12.0 (SPSS Inc., Chicago, IL, USA). All results were 
presented as the mean±standard deviation (SD). Spearman’s 
correlation analyses were used to analyze the relationships be-
tween variables and HOMA-IR, leptin, adiponectin, and A/L 
ratio. Multiple regression analyses were conducted to deter-
mine the predictor for A/L ratio and HOMA-IR after adjust-
ing for the confounding variables. A Mann-Whitney test was 
used to analyze differences in the mean adipokine levels and 
A/L ratio according to the absence or presence of MS. A P-value 
less than 0.05 was considered statistically significant.239
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 RESULTS
The general characteristics of the participants
The general characteristics of the study participants are presented 
in Table 1. The mean age of the participants was 55.1 ± 6.4 years, 
and the mean BMI of the participants was 24.4 ± 2.5 kg/m
2. 
Bivariate correlation analyses between HOMA-IR, 
adiponectin, leptin or A/L ratio, and various parameters
Serum adiponectin level showed significant negative correla-
tions with body weight, TG, and HOMA-IR (r = -0.240, P = 
0.048; r = -0.244, P = 0.045; r = -0.287, P = 0.018,  respectively) 
(Table 2). Serum leptin level showed significant positive corre-
lations with BMI (r = 0.606, P < 0.01), body weight (r=0.536, P 
< 0.01), waist circumference (r = 0.589, P < 0.01), PBF (r = 
0.814, P < 0.01), FBG (r = 0.373, P = 0.002), TC (r = 0.350, P = 
0.003), TG (r = 0.428, P < 0.01), insulin (r = 0.647, P < 0.01), 
and HOMA-IR (r = 0.688, P < 0.01) (Table 3). The A/L ratio 
was significantly correlated with the same parameters as was 
leptin, with the exception of TC (Table 3). Regarding HDL-C, 
significant correlation was shown with serum adiponectin lev-
el but not with serum leptin level or A/L ratio. In the case of 
TC, significant correlations were shown with serum leptin lev-
el but not with adiponectin level or A/L ratio. 
  HOMA-IR level correlated significantly with BMI (r = 0.474, 
P < 0.01), waist circumference (r = 0.534, P < 0.01), PBF (r = 
0.598, P < 0.01), FBG (r = 0.429, P < 0.01), TG (r = 0.410, P = 
0.001), and insulin (r = 0.970, P < 0.01). 
The comparison of mean adipokine level and A/L ratio 
according to the presence and the number of MS components 
The mean levels of leptin and HOMA-IR in subjects with MS 
were significantly higher than in those without MS (Table 4). 
In addition, subjects with MS (n = 10) showed a significantly 
lower A/L ratio compared with that of subjects without MS 
Table 1.  The general characteristics of the study subjects (n = 68)
Mean ± SD
Age, yr 55.1 ± 6.4
Weight, kg 68.8 ± 7.9
BMI, kg/m
2 24.4 ± 2.5
WC, cm 85.6 ± 6.6
PBF, % 20.3 ± 4.4
SBP, mm Hg 125.9 ± 16.0
DBP, mm Hg 76.2 ± 12.4
Fasting glucose, mg/dL 92.9 ± 18.2
Insulin, mIU/mL 5.4 ± 3.8
TC, mg/dL 196.4 ± 46.2
TG, mg/dL 155.3 ± 121.3
HDL-C, mg/dL 50.0 ± 12.0
LDL-C, mg/dL  115.5 ± 32.8
HOMA-IR 1.3 ± 1.3
Leptin, ng/mL  2.8 ± 1.5
Adiponectin, mg/mL  7.1 ± 4.0
A/L ratio  3.28 ± 2.6
Data are presented as mean ± standard deviation (SD). 
BMI, body mass index; WC, waist circumference; PBF, percent body 
fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, 
total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein 
cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, 
homeostasis model assessment-insulin resistance; A/L ratio, adipo-
nectin/leptin ratio. 
Table 2. Bivariate correlation analyses between HOMA-IR, 
adiponectin, and the variables
HOMA-IR Adiponectin
r P value r P value
Age -0.125 0.305 0.167 0.173
BMI 0.474 < 0.01 -0.187 0.127
Body weight 0.026 0.832 -0.240 0.048
WC 0.534 < 0.01 -0.218 0.077
PBF 0.598 < 0.01 -0.133 0.278
SBP 0.139 0.259 -0.038 0.758
DBP 0.237 0.052 -0.086 0.488
FBS 0.429 < 0.01 -0.172 0.161
TC 0.107 0.385 -0.006 0.964
TG 0.410 0.001 -0.244 0.045
HDL-C -0128 0.299 0.303 0.012
LDL-C -0.005 0.970 -0.067 0.586
Insulin 0.970 < 0.01 -0.060 0.633
HOMA-IR - - -0.287 0.018
Adiponectin -0.287 0.018 - -
Leptin 0.688 < 0.01 -0.128 0.297
A/L ratio -0.619 < 0.01 0.781 < 0.01
BMI, body mass index; WC, waist circumference; PBF, percent body 
fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, 
fasting blood sugar; TC, total cholesterol; TG, triglyceride; HDL-C, 
high density lipoprotein cholesterol; LDL-C, low density lipoprotein 
cholesterol; HOMA-IR, homeostasis model assessment-insulin resis-
tance; A/L ratio, adiponectin/leptin ratio.240
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(1.61 vs. 3.57, P = 0.012). The mean levels of adiponectin were 
lower in subjects with MS compared with the subjects without 
MS, but there were no statistically significant differences (4.95 
mg/mL vs. 7.46 mg/mL, P = 0.057) (Table 4). 
  The participants were divided into four groups according to 
the number of MS components (Table 4, Fig. 1). With an in-
creasing number of MS components, the mean levels of leptin 
and HOMA-IR increased (P = 0.007, P = 0.001) (Fig. 1A and B) 
and the A/L ratio decreased significantly (P = 0.033) (Fig. 1C). 
However, the level of adiponectin showed a tendency to de-
crease as the number of MS components increased, although 
this tendency was not statistically significant (P = 0.269). 
Multiple regression analyses with HOMA-IR or A/L ratio 
as the dependent variable
Multiple linear regression models with HOMA-IR or A/L ratio 
as the dependent in separate models, are presented in Table 5. 
TG and PBF were significant determinants for HOMA-IR (R
2 
= 0.564), and BMI and FBS were the significant determinants 
for A/L ratio (R
2 = 0.380) (Table 5). Also, we carried out multi-
ple linear regression analyses with HOMA-IR or A/L ratio as 
the dependent variable, including each variable in the opposite 
model (Table 6). When the analysis was performed with HOMA-
IR as the dependent variable, TG, FBS, and A/L ratio were the 
significant determinants, with a correlation coefficient for A/L 
ratio of -0.202 (R
2 = 0.593) (Table 6). When the analysis was 
performed with A/L ratio as the dependent variable, BMI and 
Table 3. Bivariate correlation analyses between leptin, A/L ra-
tio, and the variables
Leptin A/L ratio
r P value r P value
Age -0.049 0.690 0.177 0.149
BMI 0.606 < 0.01 -0.462 < 0.01
Body weight 0.536 < 0.01 -0.479 < 0.01
WC 0.589 < 0.01 -0.475 < 0.01
PBF 0.814 < 0.01 -0.557 < 0.01
SBP 0.153 0.214 -0.124 0.313
DBP 0.194 0.112 -0.177 0.149
FPG 0.373 0.002 -0.371 0.002
TC 0.350 0.003 -0.183 0.136
TG 0.428 < 0.01 -0.400 0.001
HDL-C -0.126 0.306 0.221 0.070
LDL-C 0.239 0.050 -0.147 0.232
Insulin 0.647 < 0.01 -0.591 < 0.01
HOMA-IR 0.688 < 0.01 -0.619 < 0.01
Adiponectin -0.128 0.297 0.781 < 0.01
Leptin - - -0.672 < 0.01
A/L ratio -0.672 < 0.01 - -
BMI, body mass index; WC, waist circumference; PBF, percent body 
fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, 
fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-
C, high density lipoprotein cholesterol; LDL-C, low density lipopro-
tein cholesterol; HOMA-IR, homeostasis model assessment-insulin 
resistance; A/L ratio, adiponectin/leptin ratio. 
Table 4. The comparison of mean adipokine levels and A/L ra-
tios according to the presence or absence of metabolic syn-
drome and the numbers of its components
Adiponectin,
mg/mL
Leptin,
ng/mL
HOMA-IR A/L ratio
With MS
(n = 10, 14.7%)
4.95 3.62 2.39 1.61
Without MS
(n = 58, 85.3%)
7.46 2.69 1.11 3.57
P 0.057 0.025 0.002 0.012
According to the number of MS components
0 7.80 2.02 0.71 4.47
1 7.25 2.82 1.44 3.45
2 7.40 3.14 1.09 2.93
≥ 3 4.95 3.62 2.39 1.61
P 0.269 0.007 0.001 0.03
A/L ratio, adiponectin/leptin ratio; HOMA-IR, homeostasis model 
assessment-insulin resistance; MS, metabolic syndrome.
Table 5. Multiple regression analysis with HOMA-IR or A/L 
ratio as the dependent variable
Independent 
variable
HOMA-IR A/L ratio
beta P value beta P value
Age -0.048 0.571 0.038 0.707
BMI 0.083 0.492 -0.580 < 0.01
SBP -0.022 0.814 0.25 0.807
TG -0.205 0.036 -0.093 0.410
FBS -0.166 0.094 0.727 < 0.01
PBF 0.279 0.003 -0.135 0.346
R
2 0.564 0.380
A/L ratio, adiponectin/leptin ratio; HOMA-IR, homeostasis model 
assessment-insulin resistance; BMI, body mass index; SBP, systolic 
blood pressure; TG, triglyceride; FBS, fasting blood sugar; PBF, per-
cent body fat.241
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HOMA-IR were the significant determinants, with a correla-
tion coefficient for HOMA-IR of -0.252 (R
2 = 0.413) (Table 6). 
 
DISCUSSION
The result of the present study showed that A/L ratio showed 
negatively significant correlations with PBF, lipid profiles, and 
HOMA-IR. Mean leptin and HOMA-IR levels were significant-
ly higher and A/L ratio was significantly lower in participants 
with MS. In multiple regression analysis, HOMA-IR and A/L 
ratio affected each other and were significant predictors for each 
other, suggesting that A/L ratio might be used as an insulin re-
sistance marker in healthy males. However, as expected, mod-
els including HOMA-IR as the dependent variable showed sig-
nificantly higher correlations with other metabolic parameters 
compared with model with A/L ratio as the dependent variable, 
suggesting that HOMA-IR is the stronger marker for insulin 
resistance than is the A/L ratio. 
  Inoue et al. [9,10], suggested that the A/L ratio might be more 
useful than HOMA-IR to accurately assess insulin resistance 
in participants with type 2 diabetes and also in those without 
hyperglycemia. A few previous studies have suggested that A/
L ratio was significantly associated with clamp-derived insulin 
sensitivity index [12,20], as well as that A/L ratio is an even stron-
ger predictor for insulin sensitivity than are other insulin sen-
sitivity indices, such as HOMA and QUICKI [12]. However, 
Table 6. Multiple regression analysis with HOMA-IR or A/L 
ratio as the dependent variable including the other variable in 
the model
Independent 
variable
HOMA-IR A/L ratio
beta P value beta P value
Age -0.022 0.789 0.043 0.657
BMI -0.016 0.903 -0.535 < 0.01
SBP 0.07 0.938 0.019 0.847
TG -0.229 0.017 -0.117 0.249
FBS 0.710 < 0.01 0.011 0.933
PBF 0.189 0.056 -0.093 0.514
HOMA-IR - - -0.252 0.012
A/L ratio -0.202 0.037 - -
R
2 0.593 0.413
A/L ratio, adiponectin/leptin ratio; HOMA-IR, homeostasis model 
assessment-insulin resistance; BMI, body mass index; SBP, systolic 
blood pressure; TG, triglyceride; FBS, fasting blood sugar; PBF, per-
cent body fat.
Fig. 1.  The comparison of mean values for (A) leptin, (B) 
HOMA-IR, and (C) A/L ratio according to the number of 
metabolic syndrome components. A/L ratio, adiponectin/
leptin ratio; HOMA-IR, homeostasis model assessment-insu-
lin resistance; MS, metabolic syndrome.
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in our study, HOMA-IR showed better correlation with other 
parameters related to insulin resistance, such as PBF or lipid 
profile, compared with A/L ratio, in opposition with other pre-
vious studies [11,12]. The reason that our results did not show 
the clear superiority of A/L ratio over HOMA-IR is not clear, 
but there are a few possible explanations. First, the numbers of 
participants enrolled in our study was too small to detect slight 
differences in inferiority or superiority. In fact, the numbers of 
the participants enrolled in most published studies were in the 
range of 100 to 220, compared with the 68 in our study. Sec-
ond, participants in the previous studies included both females 
and males, while our study included only males. Furthermore, 
previous studies were mainly performed with Caucasians, while 
our study focused on Asians. Adipokine levels are known to 
be different according to gender and ethnicity [13,21]. There-
fore, the discrepancy of our study result with the previous stud-
ies suggests caution at applying single study result to various 
ethnic groups.
  In this study, A/L ratio was significantly higher in those with 
MS compared with that in participants without MS. A few stud-
ies performed in Asian participants have reported similar find-
ings [16,17]. In a study performed with 2,046 Chinese adults, 
leptin/adiponectin (L/A) ratio showed a higher odds ratio in 
patients with MS and a higher area under the curve in patients 
with MS compared with those of adiponectin or leptin alone, 
suggesting the possibility of L/A ratio as the better diagnostic 
marker for MS compared with individual adipokine levels 
[16]. In a study performed in 60 Korean adults with type 2 dia-
betes, participants with MS showed a lower A/L ratio compared 
to that of those without MS [17]. Our study results are in line 
with the previous studies in that the presence of MS lead to de-
creased A/L ratio and include more supportive data on the cor-
relation of A/L ratio with MS in that A/L ratio showed signifi-
cantly decreased mean values according to increase in the num-
ber of MS components. 
  Our study has several limitations. First, as mentioned above, 
the number of participants enrolled in this study was small 
and only included males. If the study was performed in larger 
number with both male and female participants, the study re-
sult would have more impact in support of the role of A/L ra-
tio on the prediction of MS and insulin resistance. However, 
our result is meaningful in that this was the second study in 
Korean adults for the evaluation of A/L ratio with MS and in-
sulin resistance, and in that we showed that the A/L ratio var-
ied according to the number of MS components. So these data 
support the association of this novel ratio as the prediction 
marker for MS in Korean people.
  In conclusion, A/L ratio correlated well with lipid profiles, 
several anthropometric parameters, and HOMA-IR in Korean 
male participants, although HOMA-IR showed stronger cor-
relation with metabolic parameters. Furthermore, these data 
suggest that A/L ratio decreased in subjects with MS and grad-
ually decreased according to the number of MS components, 
suggesting A/L ratio as the predictive marker for MS in the 
Korean population. Further research is needed on the confir-
mation of A/L ratio as the marker for insulin resistance index 
and MS in various ethnic groups before application to clinical 
practice. 
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